The FDA has just approved a vital new weapon in the battle against drug-resistant bacteria.
Diana Sevanian
That drug, Zyvox, is described as the first entirely new type of antibiotic in 35 years. Used to treat routine pneumonia, skin infections and some drug-resistant staphylococcus infections, its chief fight will be against an infamous germ, called Enterococcus faecium— which often invades surgery wounds, as well as causing deadly infections in the abdomen, urinary tract, and heart valves. Enterococcus faecium is impervious to the current antibiotic of last resort, Vancomycin.
As more and more germs develop resistance to Vancomycin (long referred to as a “silver bullet” drug), doctors have watched helplessly as their patients die from once-treatable infections.
Those same doctors now have high hopes for Zyvox. In clinical trials of 145 patients with Vancomycin-resistant Enterococcus infections, the drug cured 67%, the Food and Drug Administration reports. But Zyvox isn’t alone in the battle against resistant bacteria.
Last fall the FDA approved competitor Aventis’ Synercid as the nation’s first alternative when Vancomycin fails.
Experts say both new drugs are important weapons that should be used sparingly and only against the worst infections, because bacteria eventually will evolve to evade them, too.
While Synercid is a combination of two older and little-used types of antibiotics, Zyvox is a brand-new chemical compound that fights germs at an entirely different point in their life cycle. Known chemically as linezolid, it is the first in a long-awaited new class of antibiotics called oxazolidinones.
It’s not a magic bullet, researchers caution, and it can’t fight all bacteria— only those known as “ gram-positive ” germs.
Still, gram-positive bacteria cause more than half of all serious infections treated in hospitals worldwide, the kind often caught by patients while they’re in the hospital for some other problem. (Those hospital acquired infections are known as “nosocomial infections.”) In clinical trials using Zyvox against other infections (including hard-to-treat staph infections), Zyvox proved as effective as Vancomycin.
The primary side effects of Zyvox are nausea and headache (in about 5% of patients.) Pharmacia said Zyvox would be available very soon, but refused to disclose the price, except to say it was expected to be a little lower than competitor Synercid.
Note: Bacterial resistance to antibiotics is responsible for increasing morbidity, mortality, and insurance costs.
The most common causes of antibiotic resistance are inappropriate use of antibiotics, such as using them to treat viral infections instead of bacterial ones, taking a “few” penicillin (like when you feel a sore throat coming on), not finishing a prescription (thereby the organism, though weakened, can still stick around in your body and develop a resistance to the drug) or using the same antibiotic over and over (the body gets immune to it.)
Always check with your doctor before taking antibiotics!
Important Facts
About Organ Donation
Currently, more than 66,000 Americans— men, women and children— are on waiting lists for lifesaving organ donations.
The National Kidney Foundation reports that each month that waiting list increases by 2,000 patients! Every day, approximately 14 people die while waiting for life-saving organ transplants.
To demystify the organ donation process and encourage more Americans to become organs donors, here are some facts on organ donation:
1. Modern medications and medical advances have resulted in transplant surgeries that are highly successful— some as high as 95 percent. Transplantation of vital organs has become routine surgical operations and are no longer experimental.
2. Most organs and tissues are donated by individuals at the time of their death. Others are donated from living donors, frequently a blood relative of the recipient.
3. Generally, donated organs are matched with individuals on an organ waiting list. Matching is based on a variety of factors, including blood and tissue types, medical need, length of time on waiting list, and weight of donor and recipient.
4. Anyone over the age of 18 can become an organ or tissue donor by signing a donor card on the back of his/her driver’s license or by contacting the National Kidney Foundation (800) 747-5527 .
Those under 18 may be able to become a donor with parental consent. It is essential, however, that anyone who wants to become a donor tell his or her family of their wishes. As loved ones of the newly deceased are asked to sign donation consent forms at the time of donation, it is important that those plans be discussed in advance.
5. Organ and tissue removal are sterile surgical procedures wherein the body remains totally intact. Open casket funerals are still possible if desired.
6. Most religious denominations favor organ/tissue donation and consider it to be a highly humanitarian act. Anyone who is unsure of how their religion views this practice should contact leaders of their church or synagogue.
7. Organs that can be donated include: kidneys, corneas, lungs, livers, pancreas’, heart valves, bones, tendons, skin and bone marrow. If desired, a donor can specify on their donor card which organs and tissues they want to donate.
U.S. Births Up for
First Time Since 1990
The U.S. birth rate increased by two percent in 1998— the first increase since 1990— reports the Center for Disease Control’s (CDC) National Center for Health Statistics. “Births: Final Data for 1998” shows that 3,941,553 babies were born in 1998, a two percent increase from 1997.
The country’s birth and fertility rates also increased slightly in 1998. The growth in the number of births was largely “fueled by increases in birth rates for women in their 20’s, the principal childbearing ages, and for women in their 30’s,” the CDC reports. Among women in their early 20’s, the 1998 birth rate was 111.2 births per 1,000 women; for women ages 25-29 , the rate increased two percent to 115.9 per 1,000.
The Washington Post reports that the study appears to be the first clear signal that the daughters of baby boom women are having children at younger ages than their mothers did, returning to a pattern more akin to that of women of earlier generations. And “because the teenage population is also growing,” the trend is likely to continue, as “large numbers of women move into the peak childbearing years,” study author Stephanie Ventura said.
The CDC report also reveals that birth rates for women in their 30’s “are at their highest in at least three decades,” at 87.4 births per 1,000 women ages 30-34 , up two percent, and 37.4 per 1,000 women ages 35-39 , up four percent.
The birth rate for women ages 40-44 increased again in 1998 to 7.3 births per 1,000 women.
Births among unwed women also rose by three percent in 1998 to 1,293,567— “the highest number ever reported.” Researchers attribute the increase to the “rise in the number of unmarried women in the childbearing ages”
According to David Landry of the Alan Guttmacher Institute, the booming economy could be playing a role in the ascending birth rate.
“Certainly it follows that as the economy does well and family income rises, most families are in a better economic position to have children,” Landry said.
